<?xml version="1.0" encoding="UTF-8"?>
<funding-group>
 <award-group id="award001">
  <funding-source>
   <institution>French Government's investissement d'Avenir Program</institution>
  </funding-source>
  <award-id>ANR-10-LABX-62IBEID</award-id>
  <principal-award-recipient>
   <name>
    <surname>Failloux</surname>
    <given-names>Anna-Bella</given-names>
   </name>
  </principal-award-recipient>
 </award-group>
 <award-group id="award002">
  <funding-source>
   <institution>Programme Opérationnel FEDER-Guadeloupe-Conseil Régional 2014-2020</institution>
  </funding-source>
  <award-id>2015-FED-192</award-id>
  <principal-award-recipient>
   <name>
    <surname>Rúa</surname>
    <given-names>Anubis Vega</given-names>
   </name>
  </principal-award-recipient>
 </award-group>
 <award-group id="award003">
  <funding-source>
   <institution>Institut Pasteur and the National Health Research Institutes</institution>
  </funding-source>
  <award-id>S-CR18039</award-id>
  <principal-award-recipient>
   <contrib-id authenticated="true" contrib-id-type="orcid">http://orcid.org/0000-0002-2113-7394</contrib-id>
   <name>
    <surname>Yen</surname>
    <given-names>Pei-Shi</given-names>
   </name>
  </principal-award-recipient>
 </award-group>
 <funding-statement>ABF was funded by French Government’s Investissement d’Avenir program, Laboratoire d’Excellence “Integrative Biology of Emerging Infectious Diseases” (grant n°ANR-10-LABX-62-IBEID); AVR was funded by FEDER grant that financed by the European Union and Guadeloupe Region, Programme Opérationnel FEDER-Guadeloupe-Conseil Régional 2014-2020 (Grant number 2015-FED-192). P-SY was supported by the Institut Pasteur and the National Health Research Institutes in Taiwan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.</funding-statement>
</funding-group>
